Professor John Wilding
John Wilding is Head of the Department of Obesity and Endocrinology at the University of Liverpool, UK. He graduated in medicine from Southampton University in 1985, where he continued his clinical training until moving to the Royal Postgraduate Medical School at Hammersmith Hospital, London where he undertook specialist training in Diabetes and Endocrinology, and three years laboratory-based research into the neurobiology of obesity and diabetes. He has been a clinical academic at the University of Liverpool, with a clinical base at Aintree Hospitals since 1996, initially as Senior Lecturer, then Reader and as Professor of Medicine since 2005.
His clinical and laboratory research focuses on the pathophysiology of obesity and its complications, especially diabetes, and evaluation of new treatments. This encompasses evaluation of novel therapeutic agents in animal models through to early and late phase clinical trials in humans and detailed physiological studies including measurements of appetite and metabolism including glucose clamp studies to evaluated insulin resistance in muscle and liver, and studies of the metabolic effects of obesity-associated respiratory disease such as sleep apnoea and asthma. His work has been funded by the British Heart Foundation, Asthma UK, Diabetes UK, and the pharmaceutical industry.
He has published over a hundred and ninety papers, chapters and review articles related to his clinical and laboratory research interests in type 2 diabetes and obesity. He is a member of the editorial boards of the International Journal of Obesity, and of Diabetes Obesity and Metabolism and an Associate Editor of Diabetic Medicine. He is Chair of the UK National Clinical Research Network Metabolic and Endocrine Speciality Group and a past Chair of the UK Association for the Study of Obesity.
